← 產業報告目錄
EV-based Liquid Biopsy Market Size, Share & Trends Analysis Report By Offering (Kits & Assays, Instruments, Services), Workflow (Sample Preparation, Sequencing, Data Analysis), Technology (Isolation And Detection Technology), Sample Type, End User, Region, And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-01頁數 180報告編號 INSIGHTACE-27daf94dfa
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The global EV-based Liquid Biopsy Market is anticipated to advance at a compound annual growth rate of 19.0% throughout the 2025–2034 forecast period.
At its core, EV-based Liquid Biopsy pertains to landscape are surgingly turning to these solutions to meet contemporary demands.
The market's upward path is bolstered by surging healthcare spending, technological evolution, and the surging focus on personalized and precision-based approaches in healthcare.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, bolstered by rapid industrialization and expanding end-user bases.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global EV-based Liquid Biopsy Market Snapshot
Chapter 4. Global EV-based Liquid Biopsy Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry
Chapter 5. Market Segmentation 1: By Offering Estimates & Trend Analysis
5.1. By Offering & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Offering:
5.2.1. Kits and Assays
5.2.2. Instruments
5.2.3. Services
Chapter 6. Market Segmentation 2: By Workflow Containers Estimates & Trend Analysis
6.1. By Offering & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Workflow Containers:
6.2.1. Sample Preparation
6.2.2. Sequencing
6.2.3. Data Analysis
Chapter 7. Market Segmentation 3: By Technology Estimates & Trend Analysis
7.1. By Offering & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Technology:
7.2.1. Isolation Technologies
7.2.1.1. Precipitation
7.2.1.2. Ultracentrifugation
7.2.1.3. Chromatography
7.2.2. Analysis Technologies
7.2.2.1. NGS
7.2.2.2. PCR
7.2.2.3. Flow Cytometry
Chapter 8. Market Segmentation 4: By Sample Type Estimates & Trend Analysis
8.1. By Offering & Market Share, 2024-2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Sample Type:
8.2.1. Blood (Plasma/Serum)
8.2.2. Urine
8.2.3. Saliva
8.2.4. Other Biofluids (CF - Cerebrospinal fluid)
Chapter 9. Market Segmentation 5: By End User Estimates & Trend Analysis
9.1. By Offering & Market Share, 2024-2034
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End User:
9.2.1. Academic and Research Institutions
9.2.2. Clinical Laboratories
9.2.3. Pharmaceutical and Biotechnology Companies
Chapter 10. EV-based Liquid Biopsy Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Offering, 2021-2034
10.1.2. North America EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Workflow Containers, 2021-2034
10.1.3. North America EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
10.1.4. North America EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By, Technology 2021-2034
10.1.5. North America EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By, Sample Type 2021-2034
10.1.6. North America EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
10.1.6.1. U.S.
10.1.6.2. Canada
10.2. Europe
10.2.1. Europe EV-based Liquid Biopsy Market revenue (US$ Million) by By Offering, 2021-2034
10.2.2. Europe EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Workflow Containers, 2021-2034
10.2.3. Europe EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
10.2.4. Europe EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Technology,2021-2034
10.2.5. Europe EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Sample Type,2021-2034
10.2.6. Europe EV-based Liquid Biopsy Market revenue (US$ Million) by country, 2021-2034
10.2.6.1. Germany
10.2.6.2. Poland
10.2.6.3. France
10.2.6.4. Italy
10.2.6.5. Spain
10.2.6.6. UK
10.2.6.7. Rest of Europe
10.3. Asia Pacific
10.3.1. Asia Pacific EV-based Liquid Biopsy Market revenue (US$ Million) by Offering, 2021-2034
10.3.2. Asia Pacific EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Workflow Containers, 2021-2034
10.3.3. Asia Pacific EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
10.3.4. Asia Pacific EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Technology, 2021-2034
10.3.5. Asia Pacific EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Sample Type, 2021-2034
10.3.6. Asia Pacific EV-based Liquid Biopsy Market revenue (US$ Million) by country, 2021-2034
10.3.6.1. China
10.3.6.2. India
10.3.6.3. Japan
10.3.6.4. Australia
10.3.6.5. Rest of Asia Pacific
10.4. Latin America
10.4.1. Latin America EV-based Liquid Biopsy Market revenue (US$ Million) by By Offering, 2021-2034
10.4.2. Latin America EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Workflow Containers, 2021-2034
10.4.3. Latin America EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
10.4.4. Latin America EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Technology, 2021-2034
10.4.5. Latin America EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Sample Type, 2021-2034
10.4.6. Latin America EV-based Liquid Biopsy Market revenue (US$ Million) by country, (US$ Million) 2021-2034
10.4.6.1. Brazil
10.4.6.2. Rest of Latin America
10.5. Middle East & Africa
10.5.1. Middle East & Africa EV-based Liquid Biopsy Market revenue (US$ Million) by By Offering, (US$ Million)
10.5.2. Middle East & Africa EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Workflow Containers, 2021-2034
10.5.3. Middle East & Africa EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
10.5.4. Middle East & Africa EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Technology, 2021-2034
10.5.5. Middle East & Africa EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Sample Type, 2021-2034
10.5.6. Middle East & Africa EV-based Liquid Biopsy Market revenue (US$ Million) by country, (US$ Million) 2021-2034
10.5.6.1. South Africa
10.5.6.2. GCC Countries
10.5.6.3. Rest of MEA
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Abcam plc
11.2.2. AMS Biotechnology Limited (AMSBIO)
11.2.3. Bio-Techne Corporation
11.2.4. Horiba Ltd.
11.2.5. Qiagen N.V.
11.2.6. Thermo Fisher Scientific, Inc.
11.2.7. Lonza Group AG
11.2.8. Malvern Panalytical Ltd
11.2.9. Revvity, Inc. (PerkinElmer, Inc.
11.2.10. Takara Bio Inc.
11.2.11. Emerging Companies
11.2.12. Mursla Bio
11.2.13. Nanostics Inc.
11.2.14. Mercy BioAnalytics, Inc.
11.2.15. Clara Diagnostics, Inc. (Clara Biotech)
11.2.16. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們